Baksh; Dolores

Patent Applications and Registrations

Patent applications and USPTO patent grants for Baksh; Dolores.The latest application filed is for "process simulation in a cell processing facility".

Company Profile

0.11.17

Baksh; Dolores - Marlborough MA
Baksh; Dolores - North Easton MA
BAKSH; Dolores - Mississauga CA
Baksh, Dolores - Ontario CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Process Simulation in a Cell Processing Facility App 20220172137 - Baksh; Dolores ; et al.	2022-06-02
Cell processing techniques Grant 10,691,773 - Wood , et al.	2020-06-23
Process Simulation in a Cell Processing Facility App 20180005156 - Baksh; Dolores ; et al.	2018-01-04
Cell Processing Techniques App 20170193168 - Wood; Nichole Lea ; et al.	2017-07-06
Progenitor Cells From Wharton's Jelly Of Human Umbilical Cord App 20170157180 - DAVIES; John E. ; et al.	2017-06-08
Progenitor cell populations, expansion thereof, and growth of non-hematopoietic cell types and tissues therefrom Grant 9,644,182 - Baksh , et al. May 9, 2	2017-05-09
Progenitor cells from wharton'S jelly of human umbilical cord Grant 9,611,456 - Davies , et al. April 4, 2	2017-04-04
Progenitor cells from Wharton's jelly of human umbilical cord Grant 9,567,564 - Davies , et al. February 14, 2	2017-02-14
Progenitor Cells From Wharton's Jelly Of Human Umbilical Cord App 20160032241 - DAVIES; John E. ; et al.	2016-02-04
Immune Privileged And Modulatory Progenitor Cells App 20150246079 - DAVIES; John E. ; et al.	2015-09-03
Immune privileged and modulatory progenitor cells Grant 8,900,573 - Davies , et al. December 2, 2	2014-12-02
Progenitor Cells From Wharton's Jelly Of Human Umbilical Cord App 20130259840 - Davies; John E. ; et al.	2013-10-03
Progenitor cells from wharton's jelly of human umbilical cord Grant 8,481,311 - Davies , et al. July 9, 2	2013-07-09
Immune Privileged And Modulatory Progenitor Cells App 20130089565 - Davies; John E. ; et al.	2013-04-11
Immune privileged and modulatory progenitor cells Grant 8,277,794 - Davies , et al. October 2, 2	2012-10-02
Bioengineered Tissue Constructs and Methods for Producing and Using Thereof App 20110293667 - Baksh; Dolores ; et al.	2011-12-01
Immune Privileged And Modulatory Progenitor Cells App 20090285842 - Davies; John E. ; et al.	2009-11-19
Progenitor Cells From Wharton's Jelly Of Human Umbilical Cord App 20090269318 - Davies; John E. ; et al.	2009-10-29
Progenitor cells from wharton's jelly of human umbilical cord Grant 7,547,546 - Davies , et al. June 16, 2	2009-06-16
Serum-Free Suspension Culture System For Mesenchymal Progenitor Cells App 20080113434 - Davies; John E. ; et al.	2008-05-15
Progenitor Cell Populations, Expansion Thereof, And Growth Of Non-hematopoietic Cell Types And Tissues Therefrom App 20080020459 - BAKSH; Dolores ; et al.	2008-01-24
Progenitor cells from wharton's jelly of human umbilical cord App 20050148074 - Davies, John E. ; et al.	2005-07-07
Progenitor cell populations , expansions thereof, and growth of non-hematopoietic cell types and tissues therefrom App 20040137612 - Baksh, Dolores ; et al.	2004-07-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.